Cite Filings / PCSA / 0001493152-26-029326

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Processa Pharmaceuticals, Inc. Filed 2026-06-18 Acc 0001493152-26-029326

Documents 1

DEF 14A Proxy Statement , formdef14a.htm

Around this filing

2026-10-22 DEF 14A Proxy Statement
2026-06-18 DEF 14A Proxy Statement
2026-06-16 4 Pres. Research & Development bought 2,067 shares at $2.22 ($4,589)
2026-06-16 4 Chief Financial Officer bought 2,654 shares at $2.22 ($5,892)
2026-06-16 4 Chief Executive Officer bought 2,465 shares at $2.22 ($5,472)
2026-06-16 4 Chief Administrative Officer bought 2,118 shares at $2.22 ($4,702)
2025-08-13 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading formdef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…